Robeco Institutional Asset Management B.V. Ionis Pharmaceuticals Inc Transaction History

Robeco Institutional Asset Management B.V.

$49.7 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 28, 2021	SELL	$34.54 - $47.25 $174,012 - $238,045	-5,038 Closed	0 $0
Q1 2021 Dec 01, 2022	BUY	$42.51 - $63.78 $214,165 - $321,323	5,038 New	5,038 $227,000
Q4 2020 Dec 01, 2022	BUY	$45.3 - $60.27 $228,221 - $303,640	5,038 New	5,038 $285,000
Q1 2020 Apr 30, 2020	SELL	$41.6 - $63.4 $268,777 - $409,627	-6,461 Reduced 56.19%	5,038 $238,000
Q4 2019 Feb 06, 2020	SELL	$53.85 - $65.27 $51,696 - $62,659	-960 Reduced 7.71%	11,499 $693,000
Q3 2019 Oct 17, 2019	BUY	$59.06 - $72.15 $173,990 - $212,553	2,946 Added 30.97%	12,459 $747,000
Q2 2019 Jul 19, 2019	BUY	$62.09 - $86.14 $590,662 - $819,449	9,513 New	9,513 $612,000

Others Institutions Holding IONS

# of Institutions

389

Shares Held

125M

Call Options Held

2.25M

Put Options Held

510K

Vanguard Group Inc Valley Forge, PA

13.8M
Shares

$550 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

12.6M
Shares

$502 Million
0.38% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$410 Million
0.01% of portfolio
Bellevue Group Ag Kuesnacht, V8

8.26M
Shares

$328 Million
6.59% of portfolio
Wellington Management Group LLP Boston, MA

6.57M
Shares

$261 Million
0.06% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account